These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9168842)
21. Uncomplicated Gilles de la Tourette syndrome and probable Ganser syndrome. A case report and review of the literature. Refaat R; Firth DA; Robertson MM Eur Child Adolesc Psychiatry; 2002 Oct; 11(5):234-9. PubMed ID: 12469241 [TBL] [Abstract][Full Text] [Related]
22. Vomiting and retching in Gilles de la Tourette syndrome: a report of ten cases and a review of the literature. Rickards H; Robertson MM Mov Disord; 1997 Jul; 12(4):531-5. PubMed ID: 9251071 [TBL] [Abstract][Full Text] [Related]
23. S100B protein, glia and Gilles de la Tourette syndrome. van Passel R; Schlooz WA; Lamers KJ; Lemmens WA; Rotteveel JJ Eur J Paediatr Neurol; 2001; 5(1):15-9. PubMed ID: 11277359 [TBL] [Abstract][Full Text] [Related]
24. Trace element and magnesium levels and superoxide dismutase activity in rheumatoid arthritis. Tuncer S; Kamanli A; Akçil E; Kavas GO; Seçkin B; Atay MB Biol Trace Elem Res; 1999 May; 68(2):137-42. PubMed ID: 10327024 [TBL] [Abstract][Full Text] [Related]
25. An individual with Gilles de la Tourette syndrome and Smith-Magenis microdeletion syndrome: is chromosome 17p11.2 a candidate region for Tourette syndrome putative susceptibility genes? Shelley BP; Robertson MM; Turk J J Intellect Disabil Res; 2007 Aug; 51(Pt 8):620-4. PubMed ID: 17598875 [TBL] [Abstract][Full Text] [Related]
26. [Effect of diabetes mellitus therapy on activity of erythrocyte superoxide dismutase]. Ciechanowski K; Bober J; Rucińska J; Machoy Z Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):17-8. PubMed ID: 8008669 [TBL] [Abstract][Full Text] [Related]
27. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Kompoliti K; Goetz CG Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740 [TBL] [Abstract][Full Text] [Related]
28. Binding of polyaminocarboxylate chelators to the active-site copper inhibits the GSNO-reductase activity but not the superoxide dismutase activity of Cu,Zn-superoxide dismutase. Ye M; English AM Biochemistry; 2006 Oct; 45(42):12723-32. PubMed ID: 17042490 [TBL] [Abstract][Full Text] [Related]
29. Genetic and clinical analysis of a large Dutch Gilles de la Tourette family. Verkerk AJ; Cath DC; van der Linde HC; Both J; Heutink P; Breedveld G; Aulchenko YS; Oostra BA Mol Psychiatry; 2006 Oct; 11(10):954-64. PubMed ID: 16894393 [TBL] [Abstract][Full Text] [Related]
30. Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome. Orth M; Kirby R; Richardson MP; Snijders AH; Rothwell JC; Trimble MR; Robertson MM; Münchau A Clin Neurophysiol; 2005 Apr; 116(4):764-8. PubMed ID: 15792884 [TBL] [Abstract][Full Text] [Related]
31. Neurological soft signs and EEG findings in children and adolescents with Gilles de la Tourette syndrome. Semerci ZB Turk J Pediatr; 2000; 42(1):53-5. PubMed ID: 10731871 [TBL] [Abstract][Full Text] [Related]
32. [Hydrogen sulfide water balneum effect on erythrocyte superoxide dismutase activity in patients with rheumatoid arthritis--in vitro study]. Grabski M; Wozakowska-Kapłon B; Kedziora J Przegl Lek; 2004; 61(12):1405-9. PubMed ID: 15850338 [TBL] [Abstract][Full Text] [Related]
34. Erythrocyte superoxide dismutase activity differs in clinical subgroups of Parkinson's disease patients. Akbostanci MC; Kocatürk PA; Tan FU; Kavas GO Acta Neurol Belg; 2001 Sep; 101(3):180-3. PubMed ID: 11817268 [TBL] [Abstract][Full Text] [Related]
35. HGPRT in the Gilles de la Tourette syndrome. Johnson GG; Pepple JM; Singer HS; Littlefield JW N Engl J Med; 1977 Aug; 297(6):339. PubMed ID: 267247 [No Abstract] [Full Text] [Related]
36. A patient with both Gilles de la Tourette's syndrome and chromosome 22q11 deletion syndrome: clue to the genetics of Gilles de la Tourette's syndrome? Robertson MM; Shelley BP; Dalwai S; Brewer C; Critchley HD J Psychosom Res; 2006 Sep; 61(3):365-8. PubMed ID: 16938515 [TBL] [Abstract][Full Text] [Related]
37. [Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study]. Neves Ramos D; van West D; van Strien AP Tijdschr Psychiatr; 2007; 49(4):263-7. PubMed ID: 17436213 [TBL] [Abstract][Full Text] [Related]
38. [Genetic linkage analysis of Gilles de la Tourette Syndrome in a Colombian family]. García-Cerén JJ; Valencia-Duarte AV; Cornejo JW; Carrizosa J; Cuartas JM; Zuluaga-Espinosa NA; Bedoya G; Ruiz-Linares A Rev Neurol; 2006 Feb 16-28; 42(4):211-6. PubMed ID: 16521059 [TBL] [Abstract][Full Text] [Related]
39. Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effects of different treatment modalities. Isler M; Delibas N; Guclu M; Gultekin F; Sutcu R; Bahceci M; Kosar A Croat Med J; 2002 Feb; 43(1):16-9. PubMed ID: 11828552 [TBL] [Abstract][Full Text] [Related]
40. Trace elements and antioxidant enzymes in Behçet's disease. Saglam K; Serce AF; Yilmaz MI; Bulucu F; Aydin A; Akay C; Sayal A Rheumatol Int; 2002 Jul; 22(3):93-6. PubMed ID: 12111082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]